Can you provide the upcoming earnings date for MIDATECH PHARMA PLC-ADR?
MIDATECH PHARMA PLC-ADR (MTP) will report earnings on 2023-04-24.
MIDATECH PHARMA PLC-ADR (MTP) Forecast, Price Target & Analyst Ratings
NASDAQ:MTP • US59564R5000
Current stock price
0.2851 USD
-0.06 (-18.52%)
At close:
0.2801 USD
-0.01 (-1.75%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MIDATECH PHARMA PLC-ADR (MTP).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
$0.00
Upside
-100.00%
From current price of $0.29 to mean target of $0.00, Based on 7 analyst forecasts
Low
$0.00
Median
$0.00
High
$0.00
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
45.71%
MTP was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about MTP.
In the previous month the buy percentage consensus was at a similar level.
MTP was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Apr 24, 2023
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 674K -65.22% | 343K -49.11% | 578K 68.51% | |
| EBITDA YoY % growth | -10.033M 3.20% | -9.454M 5.77% | -6.595M 30.24% | |
| EBIT YoY % growth | -11.318M 4.21% | -10.671M 5.72% | -6.998M 34.42% | |
| Operating Margin | -1,679.23% | -3,111.08% | -1,210.73% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in GBP
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in GBP
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
MIDATECH PHARMA PLC-ADR / MTP Forecast FAQ
How do analysts rate MIDATECH PHARMA PLC-ADR (MTP)?
The consensus rating for MIDATECH PHARMA PLC-ADR (MTP) is 45.7143 / 100 . This indicates that analysts generally have a neutral outlook on the stock.